The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Orphan Diseases-Global Market Insights and Sales Trends 2024
Synopsis
An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or "gigantism." Some diseases have patient populations of fewer than a hundred.
The global Orphan Diseases market size is expected to reach US$ 676.3 million by 2029, growing at a CAGR of 14.1% from 2023 to 2029. The market is mainly driven by the significant applications of Orphan Diseases in various end use industries. The expanding demands from the Hospital Pharmacy, Retail Pharmacy and Others,, are propelling Orphan Diseases market. Ocology, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hematology segment is estimated at % CAGR for the next seven-year period.
New rare diseases are discovered every year. Most are inherited and caused by alterations or defects in genes (mutations). Others can be acquired as a result of environmental and toxic conditions. Genes are pieces of DNA, part of the code that determines the traits and individual characteristics of all living things.
Report Objectives
This report provides market insight on the different segments, by players, by Therapy Area Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Orphan Diseases, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Orphan Diseases market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Orphan Diseases market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Orphan Diseases sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Orphan Diseases covered in this report include Bristol-Myers Squibb, Novartis, Celgene, Roche, Pfizer, Alexion, Sanofi, Vertex Pharmaceuticals and GlaxoSmithKline, etc.
The global Orphan Diseases market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb
Novartis
Celgene
Roche
Pfizer
Alexion
Sanofi
Vertex Pharmaceuticals
GlaxoSmithKline
Merck
Abbvie
Global Orphan Diseases market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Orphan Diseases market, Segment by Therapy Area Type:
Ocology
Hematology
Neurology
Endocrinology
Cardiovascular
Respiratory
Immunotherapy
Others
Global Orphan Diseases market, by Application
Hospital Pharmacy
Retail Pharmacy
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Therapy Area Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Orphan Diseases companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or "gigantism." Some diseases have patient populations of fewer than a hundred.
The global Orphan Diseases market size is expected to reach US$ 676.3 million by 2029, growing at a CAGR of 14.1% from 2023 to 2029. The market is mainly driven by the significant applications of Orphan Diseases in various end use industries. The expanding demands from the Hospital Pharmacy, Retail Pharmacy and Others,, are propelling Orphan Diseases market. Ocology, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hematology segment is estimated at % CAGR for the next seven-year period.
New rare diseases are discovered every year. Most are inherited and caused by alterations or defects in genes (mutations). Others can be acquired as a result of environmental and toxic conditions. Genes are pieces of DNA, part of the code that determines the traits and individual characteristics of all living things.
Report Objectives
This report provides market insight on the different segments, by players, by Therapy Area Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Orphan Diseases, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Orphan Diseases market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Orphan Diseases market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Orphan Diseases sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Orphan Diseases covered in this report include Bristol-Myers Squibb, Novartis, Celgene, Roche, Pfizer, Alexion, Sanofi, Vertex Pharmaceuticals and GlaxoSmithKline, etc.
The global Orphan Diseases market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb
Novartis
Celgene
Roche
Pfizer
Alexion
Sanofi
Vertex Pharmaceuticals
GlaxoSmithKline
Merck
Abbvie
Global Orphan Diseases market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Orphan Diseases market, Segment by Therapy Area Type:
Ocology
Hematology
Neurology
Endocrinology
Cardiovascular
Respiratory
Immunotherapy
Others
Global Orphan Diseases market, by Application
Hospital Pharmacy
Retail Pharmacy
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Therapy Area Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Orphan Diseases companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Orphan Diseases
1.1 Orphan Diseases Market Overview
1.1.1 Orphan Diseases Product Scope
1.1.2 Orphan Diseases Market Status and Outlook
1.2 Global Orphan Diseases Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Orphan Diseases Market Size by Region (2018-2029)
1.4 Global Orphan Diseases Historic Market Size by Region (2018-2023)
1.5 Global Orphan Diseases Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Orphan Diseases Market Size (2018-2029)
1.6.1 North America Orphan Diseases Market Size (2018-2029)
1.6.2 Europe Orphan Diseases Market Size (2018-2029)
1.6.3 Asia-Pacific Orphan Diseases Market Size (2018-2029)
1.6.4 Latin America Orphan Diseases Market Size (2018-2029)
1.6.5 Middle East & Africa Orphan Diseases Market Size (2018-2029)
2 Orphan Diseases Market by Therapy Area Type
2.1 Introduction
2.1.1 Ocology
2.1.2 Hematology
2.1.3 Neurology
2.1.4 Endocrinology
2.1.5 Cardiovascular
2.1.6 Respiratory
2.1.7 Immunotherapy
2.1.8 Others
2.2 Global Orphan Diseases Market Size by Therapy Area Type: 2018 VS 2022 VS 2029
2.2.1 Global Orphan Diseases Historic Market Size by Therapy Area Type (2018-2023)
2.2.2 Global Orphan Diseases Forecasted Market Size by Therapy Area Type (2024-2029)
2.3 Key Regions Market Size by Therapy Area Type
2.3.1 North America Orphan Diseases Revenue Breakdown by Therapy Area Type (2018-2029)
2.3.2 Europe Orphan Diseases Revenue Breakdown by Therapy Area Type (2018-2029)
2.3.3 Asia-Pacific Orphan Diseases Revenue Breakdown by Therapy Area Type (2018-2029)
2.3.4 Latin America Orphan Diseases Revenue Breakdown by Therapy Area Type (2018-2029)
2.3.5 Middle East and Africa Orphan Diseases Revenue Breakdown by Therapy Area Type (2018-2029)
3 Orphan Diseases Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacy
3.1.2 Retail Pharmacy
3.1.3 Others
3.2 Global Orphan Diseases Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Orphan Diseases Historic Market Size by Application (2018-2023)
3.2.2 Global Orphan Diseases Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Orphan Diseases Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Orphan Diseases Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Orphan Diseases Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Orphan Diseases Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Orphan Diseases Revenue Breakdown by Application (2018-2029)
4 Orphan Diseases Competition Analysis by Players
4.1 Global Orphan Diseases Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Orphan Diseases as of 2022)
4.3 Date of Key Players Enter into Orphan Diseases Market
4.4 Global Top Players Orphan Diseases Headquarters and Area Served
4.5 Key Players Orphan Diseases Product Solution and Service
4.6 Competitive Status
4.6.1 Orphan Diseases Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bristol-Myers Squibb
5.1.1 Bristol-Myers Squibb Profile
5.1.2 Bristol-Myers Squibb Main Business
5.1.3 Bristol-Myers Squibb Orphan Diseases Products, Services and Solutions
5.1.4 Bristol-Myers Squibb Orphan Diseases Revenue (US$ Million) & (2018-2023)
5.1.5 Bristol-Myers Squibb Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Orphan Diseases Products, Services and Solutions
5.2.4 Novartis Orphan Diseases Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 Celgene
5.3.1 Celgene Profile
5.3.2 Celgene Main Business
5.3.3 Celgene Orphan Diseases Products, Services and Solutions
5.3.4 Celgene Orphan Diseases Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Recent Developments
5.4 Roche
5.4.1 Roche Profile
5.4.2 Roche Main Business
5.4.3 Roche Orphan Diseases Products, Services and Solutions
5.4.4 Roche Orphan Diseases Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer Orphan Diseases Products, Services and Solutions
5.5.4 Pfizer Orphan Diseases Revenue (US$ Million) & (2018-2023)
5.5.5 Pfizer Recent Developments
5.6 Alexion
5.6.1 Alexion Profile
5.6.2 Alexion Main Business
5.6.3 Alexion Orphan Diseases Products, Services and Solutions
5.6.4 Alexion Orphan Diseases Revenue (US$ Million) & (2018-2023)
5.6.5 Alexion Recent Developments
5.7 Sanofi
5.7.1 Sanofi Profile
5.7.2 Sanofi Main Business
5.7.3 Sanofi Orphan Diseases Products, Services and Solutions
5.7.4 Sanofi Orphan Diseases Revenue (US$ Million) & (2018-2023)
5.7.5 Sanofi Recent Developments
5.8 Vertex Pharmaceuticals
5.8.1 Vertex Pharmaceuticals Profile
5.8.2 Vertex Pharmaceuticals Main Business
5.8.3 Vertex Pharmaceuticals Orphan Diseases Products, Services and Solutions
5.8.4 Vertex Pharmaceuticals Orphan Diseases Revenue (US$ Million) & (2018-2023)
5.8.5 Vertex Pharmaceuticals Recent Developments
5.9 GlaxoSmithKline
5.9.1 GlaxoSmithKline Profile
5.9.2 GlaxoSmithKline Main Business
5.9.3 GlaxoSmithKline Orphan Diseases Products, Services and Solutions
5.9.4 GlaxoSmithKline Orphan Diseases Revenue (US$ Million) & (2018-2023)
5.9.5 GlaxoSmithKline Recent Developments
5.10 Merck
5.10.1 Merck Profile
5.10.2 Merck Main Business
5.10.3 Merck Orphan Diseases Products, Services and Solutions
5.10.4 Merck Orphan Diseases Revenue (US$ Million) & (2018-2023)
5.10.5 Merck Recent Developments
5.11 Abbvie
5.11.1 Abbvie Profile
5.11.2 Abbvie Main Business
5.11.3 Abbvie Orphan Diseases Products, Services and Solutions
5.11.4 Abbvie Orphan Diseases Revenue (US$ Million) & (2018-2023)
5.11.5 Abbvie Recent Developments
6 North America
6.1 North America Orphan Diseases Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Orphan Diseases Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Orphan Diseases Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Orphan Diseases Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Orphan Diseases Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Orphan Diseases Market Dynamics
11.1 Orphan Diseases Industry Trends
11.2 Orphan Diseases Market Drivers
11.3 Orphan Diseases Market Challenges
11.4 Orphan Diseases Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
